1: Chemistry

Introduction to the Octet Rule

The octet rule states that atoms are most stable when they have eight electrons in their outermost shell (valence shell). This is why atoms tend to gain, lose, or share electrons—to achieve a full outer shell and reach a stable state, like the noble gases. The octet rule is a fundamental principle in chemistry that helps explain why atoms interact the way they do. It states that atoms are most stable when they have a full outer shell of electrons, typically eight for most elements. This drives atoms to either share, lose, or gain electrons to achieve a stable electronic configuration, similar to noble gases, which are naturally inert. For example, sodium (Na) has one valence electron, making it highly reactive as it seeks to lose that electron and become a stable Na⁺ ion. On the other hand, chlorine (Cl) has seven valence electrons and needs one more to complete its outer shell, making it eager to gain an electron and become Cl⁻. When sodium donates its electron to chlorine, they form an ionic bond, creating table salt (NaCl). This concept is crucial in understanding how molecules form and function in biological systems. In human biochemistry, ions like Na⁺, K⁺, and Cl⁻ play key roles in nerve signal transmission, muscle contraction, and maintaining fluid balance. Sodium-potassium pumps (Na⁺/K⁺ ATPase) work because sodium and potassium ions achieve stability by losing or gaining electrons, allowing nerve impulses to travel through neurons. Calcium (Ca²⁺) ions are essential for muscle contractions, as they move across membranes to trigger responses in muscle cells. Oxygen (O₂), which we breathe, forms a stable molecule by sharing electrons between two oxygen atoms in a double bond.
The octet rule helps explain why certain elements are essential for life and why imbalances in these ions can lead to health problems such as electrolyte disorders.

Take a look at the Periodic Table on Figure 1.2 and determine the number of valence electrons for the elements below:

• Sodium (Na) has 1 valence electron and will tend to lose it to become Na⁺.
• Chlorine (Cl) has 7 valence electrons and will tend to gain 1 to become Cl⁻.
• Oxygen (O) has 6 valence electrons and will tend to gain 2 to become O²⁻.

Types of Chemical Bonds and Their Importance in Biochemistry and Medicine

    Chemical bonds are the forces that hold atoms together in molecules, and they determine the structure and function of biological macromolecules such as proteins, DNA, and enzymes. The three main types of chemical bonds are covalent, ionic, and hydrogen bonds, each with distinct properties. Covalent bonds involve the sharing of electrons between atoms, forming strong and stable connections. These are essential in organic molecules, like the carbon-carbon bonds in DNA and proteins. Within covalent bonding, there are polar covalent bonds, where electrons are shared unequally, and nonpolar covalent bonds, where electrons are shared equally (Figure 1.6 and 1.7). The strength of covalent bonds ensures that enzymes can perform complex reactions without breaking apart easily.  Many drugs target covalent interactions in enzymes, like aspirin, which forms a covalent bond with an enzyme to reduce inflammation. This difference plays a role in molecular polarity, which affects solubility and interactions with other molecules.

• Nonpolar Covalent Bonds: Electrons are shared equally (e.g., O₂, H₂, CH₄).
• Polar Covalent Bonds: Electrons are shared unequally, leading to partial charges (e.g., H₂O, NH₃).

     Ionic bonds, on the other hand, form when electrons are completely transferred from one atom to another, creating positively and negatively charged ions. These bonds are weaker in aqueous solutions because water molecules can surround and separate the ions. In medicine, this is significant because many drugs are formulated as salts (such as sodium or potassium salts) to improve solubility in the bloodstream. Na⁺ and Cl⁻ form salt (NaCl), which dissolves in water to help maintain fluid balance in cells. Calcium ions (Ca²⁺) are crucial in blood clotting, muscle contractions, and nerve transmission. Many medications work by interacting with ionic sites on proteins, affecting how enzymes function.

    Hydrogen bonds are weak but critical for biological function. They occur between molecules with polar covalent bonds, such as water molecules, and play a key role in maintaining the three-dimensional structures of proteins and nucleic acids (Figure 1.8). In drug studies, hydrogen bonding is essential because it determines how a drug interacts with its target protein. Many drugs function by mimicking natural molecules and forming hydrogen bonds with enzymes or receptors, enhancing their effectiveness. For example, DNA base pairing relies on hydrogen bonding between adenine and thymine and cytosine and guanine. The double helix structure of DNA is stabilized by hydrogen bonds between base pairs (A-T and G-C).  The shape of enzymes depends on hydrogen bonding, which determines how they interact with substrates. Many drugs form hydrogen bonds with their target molecules, improving their effectiveness and specificity. Any disruption to these bonds can lead to mutations, which can have serious consequences in diseases like cancer.

   Among the various types of chemical bonds and interactions, Van der Waals interactions are usually the least taught in basic chemistry courses. However, these weak forces play a critical role in biological systems, drug interactions, and even the physical abilities of certain animals. Van der Waals forces are weak attractions that occur due to temporary shifts in electron density, creating momentary partial charges in otherwise nonpolar molecules (Figure 1.9). This temporary charge can influence nearby molecules, leading to subtle but significant conformational changes in proteins, enzymes, and other biomolecules. A useful analogy to understand Van der Waals interactions is to think of a magnet pulling all electrons to one side of a molecule. Even though the molecule may not normally have a charge, this temporary shift creates a weak attraction between it and a neighboring molecule. These induced dipoles allow nonpolar molecules, which typically do not interact strongly, to exhibit weak attractive forces. While individually weak (with bond strengths between 0.4-4 kJ/mol), these forces become significant when many such interactions occur together, contributing to molecular stability and shape. One of the most famous real-world examples of Van der Waals interactions is how geckos climb walls. Geckos have microscopic hair-like structures, called setae, on their feet (Figure 1.10). These setae branch out into even finer structures that maximize contact with surfaces, allowing the gecko to take advantage of Van der Waals forces. Even though these interactions are weak, the sheer number of tiny contacts between the gecko’s feet and a surface generates enough attraction to support the animal’s weight—allowing it to cling to walls and even walk upside down on ceilings.

     In biochemistry and medicine, Van der Waals interactions contribute to the binding specificity between drugs and their targets. Many drugs fit into enzyme active sites using a combination of hydrogen bonds, ionic interactions, and Van der Waals forces. These weak forces also help proteins fold into their correct functional shapes, ensuring biological activity. If these interactions are disrupted—such as in protein misfolding diseases like Alzheimer's—serious health consequences can occur. Therefore, despite often being overlooked, Van der Waals interactions play a vital role in both molecular stability and biological function.

Hydrophilic vs. Hydrophobic Interactions in Enzyme and Drug Studies

    Hydrophilic and hydrophobic interactions also play a crucial role in the structure and function of biological molecules. Hydrophilic molecules, which have a charge or polar groups, interact well with water and dissolve easily in aqueous environments. In contrast, hydrophobic molecules, which are nonpolar, tend to repel water and cluster together to minimize contact with it (Figure 1.11). This distinction is vital in biochemistry because the way molecules interact with water determines their function in the body.

    In enzymes and drug development, hydrophilic and hydrophobic properties influence how drugs are absorbed, distributed, and interact with their targets. For instance, cell membranes are composed of phospholipids, which have amphipathic properties—meaning they have both hydrophilic heads and hydrophobic tails. This structure forms the lipid bilayer, creating a selective barrier that controls what enters and exits the cell. Drugs designed to cross cell membranes must often have hydrophobic properties to penetrate the lipid layer, while others need to be hydrophilic to dissolve in blood plasma. Understanding these interactions allows scientists to modify drug structures for better delivery and effectiveness. Additionally, proteins fold in a way that places hydrophobic amino acids inside, away from water, while hydrophilic amino acids remain on the outside. This folding is crucial for enzyme function, and any disruption—such as in genetic diseases or misfolded proteins in Alzheimer's—can have severe consequences.

Comparison of Bond Strengths and Their Importance in Drug Development

    Understanding bond strength is crucial in drug design, as the type of bonds formed between a drug and its biological target determines how strongly and how long the drug remains active in the body. Different types of chemical bonds—covalent, ionic, hydrogen, hydrophobic interactions, and Van der Waals forces—play distinct roles in drug effectiveness, metabolism, and elimination. The stronger the bond, the more stable the interaction; however, in some cases, transient and reversible interactions are more desirable to allow for controlled biological effects.

    Covalent bonds are the strongest, with bond energies ranging from 100-1000 kJ/mol. These bonds form when two atoms share electrons, making them nearly irreversible in biological conditions. Drugs that form covalent bonds with their targets often have long-lasting effects because breaking the bond requires enzymatic intervention or protein turnover. One of the most well-known covalent inhibitors is Aspirin (Acetylsalicylic Acid), which irreversibly inhibits cyclooxygenase (COX-1 and COX-2) enzymes. By forming a covalent bond with a serine residue in the active site, aspirin permanently disables the enzyme, reducing inflammation and pain until new enzymes are synthesized. Another example is Clopidogrel (Plavix), an antiplatelet drug that covalently binds to the P2Y12 receptor on platelets, preventing clot formation in heart disease patients. Similarly, some cancer drugs, like Ibrutinib, use covalent bonding to target specific proteins, ensuring prolonged inhibition of cancer cell signaling.

    Ionic bonds, with bond strengths around 20 kJ/mol, occur due to the attraction between positively and negatively charged molecules. Many drugs exploit ionic interactions to bind to their targets while still allowing for reversible binding, which is critical for regulated biological activity. For instance, Atorvastatin (Lipitor), a cholesterol-lowering drug, binds ionically to HMG-CoA reductase, the enzyme responsible for cholesterol synthesis. This interaction effectively blocks the enzyme's function but allows for controlled drug clearance, preventing excessive cholesterol reduction. Beta-lactam antibiotics, like Penicillin, also use ionic interactions to bind to bacterial enzymes (transpeptidases), disrupting cell wall synthesis and killing bacteria.

     Hydrogen bonds, which range in strength from 12-30 kJ/mol, are vital for increasing drug selectivity and specificity. These bonds form between a hydrogen atom and electronegative elements like oxygen or nitrogen, stabilizing drug-protein interactions. A classic example is Remdesivir, an antiviral drug designed to treat COVID-19. It forms multiple hydrogen bonds with the RNA-dependent RNA polymerase (RdRp) enzyme of SARS-CoV-2, mimicking natural nucleotides and disrupting viral replication. Similarly, Oseltamivir (Tamiflu), an anti-influenza drug, relies on hydrogen bonding to fit snugly into the active site of neuraminidase, preventing viral spread.

    Hydrophobic interactions, though weaker than covalent and ionic bonds, are essential in drugs that interact with cell membranes or hydrophobic protein pockets. These interactions occur due to water exclusion, forcing nonpolar molecules together, with bond strengths typically less than 40 kJ/mol. Drugs like Tamoxifen, used in breast cancer treatment, bind to estrogen receptors via hydrophobic interactions, blocking estrogen signaling and slowing cancer growth. Similarly, Statins (such as Simvastatin and Atorvastatin) fit into the hydrophobic active site of HMG-CoA reductase, reducing cholesterol synthesis.

    Van der Waals forces, the weakest of all at 0.4-4 kJ/mol, occur due to temporary dipole-induced attractions. Although weak, these interactions contribute significantly to drug-receptor binding stability and fine-tuning molecular fit. One example is Benzodiazepines (like Diazepam/Valium and Alprazolam/Xanax), which bind to GABA-A receptors through a combination of hydrogen bonds and Van der Waals forces. These interactions help modulate receptor activity, producing anxiolytic (anti-anxiety) effects. Another example is HIV protease inhibitors (such as Ritonavir and Lopinavir), which use Van der Waals interactions to snugly fit into the hydrophobic pocket of HIV protease, preventing viral replication.

    A deep understanding of bond strength is essential in drug design because different therapeutic goals require different types of binding interactions. Covalent inhibitors offer long-lasting effects but must be used cautiously to avoid off-target toxicity. Ionic and hydrogen bonds allow for strong, yet reversible interactions, ensuring drug effectiveness while preventing excessive buildup. Hydrophobic and Van der Waals forces help improve drug specificity, allowing precise molecular targeting. By fine-tuning these interactions, pharmaceutical scientists can develop drugs with optimal binding, selectivity, and duration of action, leading to more effective and safer treatments for diseases.

Bond Strength Comparison

Table 1.1: Bond Strength Comparison between covalent, ionic, hydrogen, hydrophobic interactions, and Van der Waals forces